These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 22892060

  • 1. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.
    Fahlén M, Fornander T, Johansson H, Johansson U, Rutqvist LE, Wilking N, von Schoultz E.
    Eur J Cancer; 2013 Jan; 49(1):52-9. PubMed ID: 22892060
    [Abstract] [Full Text] [Related]

  • 2. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL, Ingvar C, Bladström A.
    Cancer; 2003 Mar 15; 97(6):1387-92. PubMed ID: 12627501
    [Abstract] [Full Text] [Related]

  • 3. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
    Holmberg L, Iversen OE, Rudenstam CM, Hammar M, Kumpulainen E, Jaskiewicz J, Jassem J, Dobaczewska D, Fjosne HE, Peralta O, Arriagada R, Holmqvist M, Maenpaa J, HABITS Study Group.
    J Natl Cancer Inst; 2008 Apr 02; 100(7):475-82. PubMed ID: 18364505
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec 02; 15(6):453-65. PubMed ID: 11826770
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Is HRT justified for symptom management in women at higher risk of developing breast cancer?
    Rippy L, Marsden J.
    Climacteric; 2006 Dec 02; 9(6):404-15. PubMed ID: 17085372
    [Abstract] [Full Text] [Related]

  • 8. HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped.
    Holmberg L, Anderson H, HABITS steering and data monitoring committees.
    Lancet; 2004 Feb 07; 363(9407):453-5. PubMed ID: 14962527
    [Abstract] [Full Text] [Related]

  • 9. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
    Schuetz F, Diel IJ, Pueschel M, von Holst T, Solomayer EF, Lange S, Sinn P, Bastert G, Sohn C.
    Am J Obstet Gynecol; 2007 Apr 07; 196(4):342.e1-9. PubMed ID: 17403414
    [Abstract] [Full Text] [Related]

  • 10. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
    Wang Y, Lewin N, Qaoud Y, Rajaee AN, Scheer AS.
    Breast; 2018 Aug 07; 40():123-130. PubMed ID: 29763858
    [Abstract] [Full Text] [Related]

  • 11. [Estrogen replacement therapy and breast cancer].
    Bakken K, Alsaker E, Eggen AE, Lund E.
    Tidsskr Nor Laegeforen; 2005 Feb 03; 125(3):282-5. PubMed ID: 15702147
    [Abstract] [Full Text] [Related]

  • 12. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr 03; 12(64):65-9. PubMed ID: 12674130
    [Abstract] [Full Text] [Related]

  • 13. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
    Beral V, Banks E, Reeves G.
    Lancet; 2002 Sep 21; 360(9337):942-4. PubMed ID: 12354487
    [Abstract] [Full Text] [Related]

  • 14. A case-control study of hormone replacement therapy after primary surgical breast cancer treatment.
    Ursic-Vrscaj M, Bebar S.
    Eur J Surg Oncol; 1999 Apr 21; 25(2):146-51. PubMed ID: 10218456
    [Abstract] [Full Text] [Related]

  • 15. Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries.
    Zbuk K, Anand SS.
    J Epidemiol Community Health; 2012 Jan 21; 66(1):1-7. PubMed ID: 21875869
    [Abstract] [Full Text] [Related]

  • 16. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK, Chick P.
    Med J Aust; 1992 Jan 20; 156(2):124-32. PubMed ID: 1736053
    [Abstract] [Full Text] [Related]

  • 17. Hormone replacement therapy in breast cancer survivors.
    Xydakis AM, Sakkas EG, Mastorakos G.
    Ann N Y Acad Sci; 2006 Dec 20; 1092():349-60. PubMed ID: 17308160
    [Abstract] [Full Text] [Related]

  • 18. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter].
    Siegelmann-Danieli N, Ron I, Kaufman B, Uzieli B, Karminsky N, Inbar M, Israeli Society for Clinical Oncology and Radiotherapy.
    Harefuah; 2004 Oct 20; 143(10):753-6, 764. PubMed ID: 15521355
    [Abstract] [Full Text] [Related]

  • 19. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
    Dew JE, Wren BG, Eden JA.
    Climacteric; 2002 Jun 20; 5(2):151-5. PubMed ID: 12051110
    [Abstract] [Full Text] [Related]

  • 20. Breast cancer risk during hormone therapy: experimental versus clinical data.
    Ruan X, Seeger H, Mueck AO.
    Minerva Endocrinol; 2012 Mar 20; 37(1):59-74. PubMed ID: 22382615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.